By Eric L. Foxman, Pharm. (Ret.), HPUS Senior Scientist, HPUS Chairman of Counsel on Pharmacy, and HPUS Board Member A major upgrade and overhaul of...
Summary of FDA’s “Report on the State of Pharmaceutical Quality: Fiscal year 2021”
By Mark Land, M.S., RAC, AAHP President Introduction In August of 2022, the United States Food and Drug Administration (FDA) published its fourth annual Report...
More Snapshots From the There and Then
Ukraine Homeopathy had a firm foundation in Ukraine during Hahnemann's lifetime. With the support and public use by Russian royalty, prominent aristocrats, and merchants. and...
What’s new at FDA?
The United States Food and Drug Administration is a large organization that changes daily. From the perspective of homeopathic companies, a few important things stand...
AAHP Reader Favorites for 2022
As we enter 2023, it's time to look back at our top articles of 2022. These five pieces were the most-read content over the past...
2023 Marks 100 Years of Success
By Mark Land, AAHP President This year AAHP turns 100 years old. Over that time, our association has represented the interests of homeopathic manufacturers with...
Snapshots From the There and Then
In honor of AAHP's 100th Anniversary (1923-2023) year, we look back at the history of homeopathy to find out how this medical modality spread around...
FTC Updates Health Claims Substantiation Guidance
By Alvin J. Lorman, AAHP Legal Counsel In December 2022, the Federal Trade Commission released a lengthy guidance document on the substantiation it expects for...
FDA Finalizes Homeopathic Guidance
By Alissa Gould, AAHP Communications Chair Seven years after the U.S. Food and Drug Administration (FDA) held a public hearing on homeopathic product regulation and...